Literature DB >> 12709000

Acral lentiginous melanoma: an immunohistochemical study of 20 cases.

You Chan Kim1, Min Geol Lee, Sung Whan Choe, Min Cheol Lee, Han Gil Chung, Sang-Ho Cho.   

Abstract

BACKGROUND: Though acral lentiginous melanoma (ALM) is a major type of malignant melanoma, no immunohistochemical study on this type of melanoma has been reported.
OBJECTIVE: The purpose of this study is to analysis the immunohistochemical findings of ALM using routinely used immune markers.
METHODS: An immunohistochemical study was performed on paraffin sections of 20 ALMs using S-100 protein, HMB-45, MART-1, vimentin, epithelial membrane antigen (EMA) and CAM 5.2.
RESULTS: S-100 protein (95%) was found to be a more sensitive marker than either HMB-45 (80%) or MART-1 (70%) for recognizing ALM. Melanin bleaching was useful for recognizing heavily pigmented ALM using both S-100 protein and HMB-45. The intensity of HMB-45 correlated well with the melanin content. However, there was no significant correlation between the intensity of S-100 protein and the melanin content. One and two out of 20 cases stained focally with EMA and CAM5.2, respectively, but these cases stained also with HMB-45 and/or S-100 protein.
CONCLUSIONS: S-100 protein and HMB-45 were relatively sensitive markers for recognizing ALM. Despite the occasional positivity for the epithelial markers in ALM, all epithelial marker-positive cases stained also with HMB-45 and/or S-100 protein. Therefore, we recommend that the panel of antibodies used for recognizing ALM should contain at least S-100 protein and HMB-45.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709000     DOI: 10.1046/j.1365-4362.2003.01583.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

Review 1.  Melanocytic nevi simulant of melanoma with medicolegal relevance.

Authors:  Guido Massi
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

2.  Expression of EpCAM in uveal melanoma.

Authors:  Danilo N Odashiro; Alexandre N Odashiro; Patrícia R Pereira; Katyanne Godeiro; Emilia Antecka; Sebastian Di Cesare; Miguel N Burnier
Journal:  Cancer Cell Int       Date:  2006-11-24       Impact factor: 5.722

Review 3.  Advanced Acral Melanoma Therapies: Current Status and Future Directions.

Authors:  Yiqun Zhang; Shijie Lan; Di Wu
Journal:  Curr Treat Options Oncol       Date:  2022-09-20

Review 4.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08

Review 5.  Cutaneous Melanoma in Asians.

Authors:  Sang Yub Kim; Sook Jung Yun
Journal:  Chonnam Med J       Date:  2016-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.